News

Labcorp Holdings Inc. ( NYSE: LH) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Investor Relations ...
Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...
The company also offers platform-agnostic next-generation sequencing tests and a suite of sample prep and thermal cycling instruments.
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond laboratory ...
First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study ...
First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early ...
New data shows nearly 7% of adults, roughly 18 million people, reported ever having long-term symptoms and nearly 9 million say they are still dealing with it.
A new study has found that a simple blood test may be a powerful way to detect early signs of Alzheimer’s disease, even in people with cerebrovascular disease (CeVD), which is common among ...
Developed by Exact Sciences, the Oncodetect test is a tumor-informed molecular residual disease (MRD) test designed to provide a personalized approach to detecting and monitoring residual cancer in ...
Alzheimer’s disease (AD) and AD-related dementias (ADRD) represent a significant health challenge, with a growing impact on marginalized populations who often experience inequities in overall ...